Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Delayed puberty secondary prevention
Introduction
Overview
Overview
Effective measures for the secondary prevention of delayed puberty are prompt diagnosis and hormone replacement therapy to prevent osteoporosis, short adult height along with salpingo-oophorectomy in Turner syndrome, to prevent malignancy.
Secondary Prevention
Secondary Prevention
- Effective measures for the secondary prevention of delayed puberty include:
- Prompt diagnosis, and hormone replacement therapy in order to prevent osteoporosis and short adult height.
- Salpingo-oophorectomy in Turner syndrome to prevent malignancy.
- It seems that delayed puberty can lead to lower bone mineral density (BMD) in adulthood.[1]
- Since the lower BMD is the main risk factor for fracture, therefore untreated delayed puberty leads to more fracture rate.[2]
- Hormone therapy in boys, but not girls, with short stature and delayed puberty improves the adult height, proportionally.[3]
- Timely initiation of hormonal therapy can also prevent any psychological problems in children with delayed puberty.[4]
References
References
- ↑ Finkelstein, Joel S.; Neer, Robert M.; Biller, Beverly M.K.; Crawford, John D.; Klibanski, Anne (1992). “Osteopenia in Men with a History of Delayed Puberty”. New England Journal of Medicine. 326 (9): 600–604. doi:10.1056/NEJM199202273260904. ISSN 0028-4793.
- ↑ Johnston CC, Slemenda CW, Melton LJ (1991). “Clinical use of bone densitometry”. N. Engl. J. Med. 324 (16): 1105–9. doi:10.1056/NEJM199104183241606. PMID 2008183.
- ↑ Zucchini S, Wasniewska M, Cisternino M, Salerno M, Iughetti L, Maghnie M, Street ME, Caruso-Nicoletti M, Cianfarani S (2008). “Adult height in children with short stature and idiopathic delayed puberty after different management”. Eur. J. Pediatr. 167 (6): 677–81. doi:10.1007/s00431-007-0576-y. PMID 17717702.
- ↑ Pozo J, Argente J (2003). “Ascertainment and treatment of delayed puberty”. Horm. Res. 60 Suppl 3: 35–48. doi:74498 Check
|doi=value (help). PMIDÂ 14671394.
​
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]